Skip to main content

Table 1 Patients’ characteristics

From: Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma

Total 79
Age (years)
 Mean ± SD; range 58.9 ± 13.4; 27–84
 Median 61
Gender (male) 47 (60%)
Myasthenia gravis 15 (19%)
 MGFA class I 13
 MGFA class IIa 1
 MGFA class IIb 1
Neoadjuvant therapy 3 (4%)
 Chemotherapy 2
 Chemo-radiotherapy 1
Adjuvant radiotherapy 47 (60%)
Surgical approach
 Median sternotomy 65 (82%)
 Thoracotomy 4 (5%)
 VATS 10 (13%)
Surgical procedure
 Complete thymectomy 64 (81%)
 Extended thymectomy 15 (19%)
WHO classification
 A 5 (6%)
 AB 32 (41%)
 B1 16 (20%)
 B2 11 (14%)
 B3 15 (19%)
Masaoka-Koga stage
 I 21 (27%)
 II 41 (52%)
 III 16 (20%)
 IV 1 (1%)
TNM stage
 I 65 (82%)
 II 2 (3%)
 IIIA 11 (14%)
 IIIB 1 (1%)